Favipiravir for treatment of outpatients with asymptomatic or uncomplicated COVID-19: a double-blind randomized, placebo-controlled, phase 2 trial
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2022) - Comments
doi: 10.1093/cid/ciac312  issn: 1058-4838  issn: 1537-6591  pubmed: 35446944 

Marisa Holubar, Aruna Subramanian, Natasha Purington, Haley Hedlin, Bryan Bunning, Katharine S. Walter, Hector Bonilla, Athanasia Boumis, Michael Chen, Kimberly Clinton, Liisa Dewhurst, Carol Epstein, Prasanna Jagannathan, Richard H. Kaszynski, Lori Panu, Julie Parsonnet, Elizabeth L. Ponder, Orlando Quintero, Elizabeth Sefton, Upinder Singh